Becton, Dickinson and Company BDX Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Segment Other Operating Expense (Income), net as a Percent of Revenues by Business | ||||||
| BioPharma Systems | 0%— | 0%— | —— | —— | 0%— | |
| Connected Care | 0.3%0.0pp | 0.3%— | —— | —— | 0.2%-0.4pp | |
| Interventional | 0%— | 0%— | —— | —— | 0%— | |
| Medical Essentials | 0%— | 0%— | —— | —— | 0%— | |
| Revenue, remaining performance obligation, amount by Product | ||||||
| Consumables | $2B-16.7% | $2.4B+4.3% | $2.3B0.0% | $2.3B+4.5% | $2.2B+10.0% | |
| Products and/or Services | $2.3B-8.0% | $2.5B-10.7% | $2.8B+12.0% | $2.5B+4.2% | $2.4B+4.3% | |
| Revenue by Geography | ||||||
| International | $1.8B-14.1% | $2.09B-15.2% | $2.47B+6.0% | $2.33B+36.6% | $1.7B-18.4% | |
| UNITED STATES | $2.92B-7.7% | $3.16B-7.7% | $3.42B+7.5% | $3.18B+14.6% | $2.78B-9.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Becton, Dickinson and Company break its business down?
- Becton, Dickinson and Company (BDX) reports segment other operating expense (income), net as a percent of revenues by business across 5 parts — BioPharma Systems, Connected Care, Interventional, Medical Essentials and Medical. Each is extracted from the segment footnotes and tracked over time.
- Where does Becton, Dickinson and Company's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Becton, Dickinson and Company's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
